Note: Ingredients listed on restricted chemical lists
EC/CAS
200-578-6/64-17-5
Name of the chemical
Ethanol
Concentration
>=10-<20
General Information
Version
1.0
Revision date
2019-10-29
Product name
Metacam solution for injection (finished product)
Product Synonyms
Metacam® 2 mg/ml solution for injection, Metacam® 5 mg/ml solution for injection, Metacam® 20 mg/ml solution for injec- tion, Metacam® 40 mg/ml solution for injection Wirkstoff: Meloxicam
1.2.1 Relevant identified uses
Pharmaceutical
1.2.2. Uses advised against
Safety Data Sheet only for the professional user on use
Emergency telephone
+498007790900, +1 703-527-3887
Icons in SDS
Company Information
company name
Boehringer Ing. Pharma GmbH & Co. KG
e-mail address of the competent person responsible for the Safety Data Sheet
EHS-Services@Boehringer-Ingelheim.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H226, H302, H319, H361
Hazard statements
Code
Statements
H226
Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Warning
Hazard statements
H226 Flammable liquid and vapour. H302 Harmful if swallowed. H319 Causes serious eye irritation. H361 Suspected of damaging fertility or the unborn child.
Prevention
P201 Obtain special instructions before use. P210 Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P264 Wash skin thoroughly after handling. P280 Wear protective gloves/ protective clothing/ eye protec- tion/ face protection.
Response
P303 + P361 + P353 IF ON SKIN (or hair): Take off immedi- ately all contaminated clothing. Rinse skin with water. P370 + P378 In case of fire: Use dry sand, dry chemical or alcohol-resistant foam to extinguish.
Hazardous Ingredients
Meloxicam
Additional information
The following percentage of the mixture consists of ingredient(s) with unknown acute dermal tox- icity: 7,8 %
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumula- tive and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher This drug is not subject to the labelling requirements under the Globally Harmonized System (GHS) The pharmacological effect of the medicament has to be considered (see package leaflet).
2.1 Classification of the substance or mixture
Classification (REGULATION (EC) No 1272/2008) Flammable liquids , Category 3 H226: Flammable liquid and vapour. Acute toxicity , Category 4 H302: Harmful if swallowed. Eye irritation , Category 2 H319: Causes serious eye irritation. Reproductive toxicity , Category 2 H361: Suspected of damaging fertility or the un-
